Cargando…

Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma

BACKGROUND: Many long intergenic noncoding RNAs (lincRNAs) are encoded in the human genome. However, their biological functions, molecular mechanisms and prognostic values associated with clear cell renal cell carcinoma (ccRCC) have yet to be elucidated. METHODS: We screened the lncRNAs’ profile in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Haibing, Bao, Lin, Xiao, Wen, Ruan, Hailong, Song, Zhengshuai, Qu, Yan, Chen, Ke, Zhang, Xiaoping, Yang, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768351/ https://www.ncbi.nlm.nih.gov/pubmed/29371934 http://dx.doi.org/10.18632/oncotarget.21185

Ejemplares similares

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2017)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis
por: Wang, Xiaojun, et al.
Publicado: (2021)

LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
por: Wang, KeShan, et al.
Publicado: (2019)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2019)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2022)

The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans
por: Agarwal, Shiuli, et al.
Publicado: (2020)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Long non‐coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma
por: Lou, Yun, et al.
Publicado: (2018)

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer
por: Song, Zhengshuai, et al.
Publicado: (2019)

Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression
por: Sun, Yue, et al.
Publicado: (2017)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma
por: Song, Zhengshuai, et al.
Publicado: (2020)

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
por: Meng, Xiangui, et al.
Publicado: (2020)

LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR‐375 expression
por: Zhang, Kai, et al.
Publicado: (2021)

The screening of pivotal gene expression signatures and biomarkers in renal carcinoma
por: Ruan, Hailong, et al.
Publicado: (2019)

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Xuegang, et al.
Publicado: (2023)

MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2015)

Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
por: Tao, Yue, et al.
Publicado: (2021)

Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
por: Tao, Yue, et al.
Publicado: (2022)

Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2019)

SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Lilong, et al.
Publicado: (2021)

Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
por: Huan, Lin, et al.
Publicado: (2020)

LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer
por: Luzón-Toro, B., et al.
Publicado: (2019)

Long non-coding RNA LUCAT1 inhibits myocardial oxidative stress and apoptosis after myocardial infarction via targeting microRNA-181a-5p
por: Xiao, Shi-Hui, et al.
Publicado: (2021)

LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn's Disease
por: Kuai, Xiao-yi, et al.
Publicado: (2021)

LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression
por: Wu, Runliu, et al.
Publicado: (2020)

Long Noncoding RNA LUCAT1 Promotes Multiple Myeloma Cell Growth by Regulating the TGF-β Signaling Pathway
por: Liu, Zhaoyu, et al.
Publicado: (2020)

Knockdown of Long Noncoding RNA LUCAT1 Inhibits Cell Viability and Invasion by Regulating miR-375 in Glioma
por: Gao, Yan-Sheng, et al.
Publicado: (2018)

Long Non-Coding RNA LUCAT1 Promotes Progression of Thyroid Carcinoma by Reinforcing ADAM10 Expression Through Sequestering microRNA-493
por: Xiong, Guofeng, et al.
Publicado: (2020)

An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification
por: Zhang, Yinglang, et al.
Publicado: (2021)

ELF1‐mediated LUCAT1 promotes choroidal melanoma by modulating RBX1 expression
por: Wang, Lina, et al.
Publicado: (2020)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway
por: Jin, Tingting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9cmeukaeet8v2g64pj0vrrpe8i